- Home
- NTB vs BCRX Comparison
NTB vs BCRX Comparison
Compare NTB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- BCRX
- Stock Information
- Founded
- NTB 1858
- BCRX 1986
- Country
- NTB Bermuda
- BCRX United States
- Employees
- NTB N/A
- BCRX N/A
- Industry
- NTB Commercial Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTB Finance
- BCRX Health Care
- Exchange
- NTB Nasdaq
- BCRX Nasdaq
- Market Cap
- NTB 1.7B
- BCRX 1.7B
- IPO Year
- NTB 2016
- BCRX 1994
- Fundamental
- Price
- NTB $41.05
- BCRX $9.97
- Analyst Decision
- NTB Buy
- BCRX Buy
- Analyst Count
- NTB 4
- BCRX 8
- Target Price
- NTB $44.25
- BCRX $16.75
- AVG Volume (30 Days)
- NTB 182.3K
- BCRX 5.9M
- Earning Date
- NTB 04-23-2025
- BCRX 05-05-2025
- Dividend Yield
- NTB 4.28%
- BCRX N/A
- EPS Growth
- NTB 7.68
- BCRX N/A
- EPS
- NTB 4.81
- BCRX N/A
- Revenue
- NTB $585,277,000.00
- BCRX $503,485,000.00
- Revenue This Year
- NTB N/A
- BCRX $27.64
- Revenue Next Year
- NTB $0.79
- BCRX $13.42
- P/E Ratio
- NTB $8.52
- BCRX N/A
- Revenue Growth
- NTB 1.89
- BCRX 41.67
- 52 Week Low
- NTB $32.78
- BCRX $5.06
- 52 Week High
- NTB $41.88
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- NTB 66.29
- BCRX 65.89
- Support Level
- NTB $40.32
- BCRX $9.83
- Resistance Level
- NTB $41.42
- BCRX $11.11
- Average True Range (ATR)
- NTB 0.86
- BCRX 0.51
- MACD
- NTB 0.19
- BCRX 0.20
- Stochastic Oscillator
- NTB 86.59
- BCRX 68.33
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.